ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

2024 Surescripts White Coat Award Recognizes 10 Healthcare Technology Leaders in Performance, Innovation and Accuracy

Surescripts®, the nation's leading health information network, awarded the 2024 Surescripts White Coat Award™ to 10 healthcare industry leaders, recognizing their commitment to performance, innovation and accuracy.

The 2024 Surescripts White Coat Award winners achieved excellence across three categories, including Highest Performance, Innovation and RxChange Champion. This year’s winners include the following leaders from across healthcare:

  1. athenahealth
  2. Cleveland Clinic
  3. CVS Pharmacy
  4. DAW Systems, Inc. (ScriptSure)
  5. Epic
  6. Greenway HealthTM
  7. Hamilton Health Care System
  8. Lexington Medical Center
  9. SRS Pharmacy Systems
  10. Walmart

“We are thrilled to recognize the 2024 White Coat Award recipients for continually raising the bar for accuracy, adopting best practices and technology enhancements that ensure clinicians are equipped to provide quality, safe and effective care that their patients deserve,” said Frank Harvey, Chief Executive Officer for Surescripts. “For more than two decades, the Surescripts Network Alliance has continued to prioritize accuracy and patient safety for the billions of e-prescriptions processed each year. This commitment means prescribers and pharmacists are spending less time clarifying the prescriber’s intent and more time focused on what matters most – the patients in their care.”

The 2024 Surescripts White Coat Award recognizes health systems, pharmacies, pharmacy technology vendors and electronic health records (EHR) vendors that help deliver clear and accurate electronic prescriptions, eliminate confusion and time-consuming phone calls and faxes, and give patients better access to the medications they need. Winners are recognized for excellence in three categories:

  • Highest Performance: best overall performance score across e-prescriptions
  • RxChange Champion: successfully advancing the RxChange transaction, which lets pharmacies communicate with prescribers to resolve prescription concerns within their electronic workflow.
  • Innovation: driving performance optimization across the healthcare continuum, ensuring prescribers and pharmacists can provide quality care to patients in a timely manner.

In 2023, Surescripts processed 2.5 billion e-prescriptions, 204.1 million CancelRx Requests and 34.6 million RxChange Requests.

Surescripts continues to improve electronic prescribing with innovations like Sig IQ technology that translates free-text patient directions into a quality-controlled, clinically validated format in order to protect prescriber intent and patient safety. This capability was originally developed to enhance medication histories, Sig IQ expanded to add a Structured & Codified Sig to 1.4 million RxRenewal Requests sent by pharmacies in Q4 2023, allowing prescribers to approve these requests in fewer keystrokes.

About Surescripts

Our purpose is to serve the nation through simpler, trusted health intelligence sharing, in order to increase patient safety, lower costs and ensure quality care. At Surescripts, we align healthcare organizations across the nation and convene the Surescripts Network Alliance® to give healthcare professionals the trusted insights they need to serve patients. Together, we’re making interoperability an everyday reality, making it simpler to choose medications patients can afford and adhere to, and getting specialty medications to patients more efficiently. Visit us at surescripts.com and follow us on LinkedIn.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.